BioHarvest SciencesBHST -1.42%63 Days Payable is 69.80 as of Mar. 2026, which is 17% below its 10-year median of 84.45. GuruFocus rates BHST with a GF Score™ of 63/100 and a GF Value™ of $8.57 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 1,884 Consumer Packaged Goods companies, BioHarvest Sciences ranks better than 77.23% on this metric.
The historical rank and industry rank for BioHarvest Sciences's Days Payable or its related term are showing as below:
BHST'
s Days Payable Range Over the Past 10 Years
Min: 73.76 Med: 84.45 Max: 326.8
Current: 81.78
During the past 12 years, BioHarvest Sciences's highest Days Payable was 326.80. The lowest was 73.76. And the median was 84.45.
BHST's Days Payable is ranked better than 77.23% of 1884
companies
in the Consumer Packaged Goods industry
Industry Median: 43.885
vs BHST: 81.78
BioHarvest Sciences's Days Payable
declined
from Mar. 2025 (101.44) to Mar. 2026 (69.80).
It may suggest that BioHarvest Sciencesaccelerated paying its suppliers.
BioHarvest Sciences Days Payable Related Terms
BioHarvest Sciences Days Payable Historical Data
* Premium members only.
The historical data trend for BioHarvest Sciences's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, BioHarvest Sciences's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BioHarvest Sciences Days Payable vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, BioHarvest Sciences's Days Payable distribution charts can be found below:
* The bar in red indicates where BioHarvest Sciences's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
BioHarvest Sciences's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BioHarvest Sciences (BHST) has a Days Payable of 69.80 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on BioHarvest Sciences and its competitors. This is 17% below median its historical median of 84.45. Over the past decade, BioHarvest Sciences' Days Payable has ranged from 73.76 to 326.80. According to the industry distribution chart, BioHarvest Sciences ranks #429 out of 1884 companies in the Consumer Packaged Goods industry, placing it in the top 22.8%.
Is BioHarvest Sciences' Days Payable too high?
BioHarvest Sciences' current Days Payable of 69.80 is 17% below median its 10-year median of 84.45. Over the past 10 years, this metric has ranged from a low of 73.76 to a high of 326.80. The Consumer Packaged Goods industry median Days Payable is 43.89. BioHarvest Sciences' value of 69.80 is 59.1% above this industry median. Based on the distribution chart, BioHarvest Sciences ranks #429 out of 1884 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, BioHarvest Sciences has a GF Score™ of 63/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does BioHarvest Sciences' Days Payable compare to GWLL and CLNN?
According to the Consumer Packaged Goods industry distribution chart, BioHarvest Sciences ranks #429 out of 1884 companies for Days Payable. This places BioHarvest Sciences in the top 23% of its industry — outperforming the majority of peers. The industry median Days Payable is 43.89. BioHarvest Sciences' value of 69.80 is 59.1% above this benchmark. Historically, BioHarvest Sciences' own Days Payable has ranged from 73.76 to 326.80 over the past decade. While the company's 10-year median is 84.45 vs. the industry median of 43.89, BioHarvest Sciences has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Consumer Packaged Goods company?
The median Days Payable among Consumer Packaged Goods companies is 43.89, based on 1,884 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BioHarvest Sciences's current Days Payable of 69.80 is 59.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on BioHarvest Sciences and its competitors. For the Consumer Packaged Goods industry, the median Days Payable is 43.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BioHarvest Sciences's current Days Payable is 69.80, which is 17% below median its own 10-year median of 84.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioHarvest Sciences stock overvalued right now?
Based on GuruFocus' analysis, BioHarvest Sciences (BHST) is currently considered Possible Value Trap. The stock's GF Value™ is $8.57, compared to a current price of $2.77 — trading 67.7% below its estimated fair value. The current Days Payable is 69.80, which is 17% below median its 10-year median of 84.45 and 59.1% above the Consumer Packaged Goods industry median of 43.89. BioHarvest Sciences' overall GF Score™ is 63/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For BioHarvest Sciences (BHST), the current Days Payable is 69.80 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BioHarvest Sciences (BHST) Overvalued in 2026?
Based on GuruFocus' analysis, BioHarvest Sciences stock appears to be undervalued.
The current stock price of $2.77 is trading 67.7% below its estimated GF Value™ of $8.57.
GuruFocus considers BioHarvest Sciences to be Possible Value Trap.
Key valuation signals for BHST:
Days Payable: 69.80 (17% below median its 10-year median of 84.45)
GF Value™: $8.57 vs. price of $2.77 (67.7% below fair value)
Industry Position: 59.1% above the Consumer Packaged Goods median (#429 of 1884)
No single metric tells the full story. See the BHST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. The Company has two operating segments or business units: the Products business unit and the CDMO Services business unit. In identifying these operating segments, management generally follows the Company's service lines representing its main products and services. The Products Business Unit - Nutraceuticals: Research, development, manufacturing, marketing and sales of science-based health and wellness nutraceutical solutions which are manufactured and sold as dietary supplements, functional food and beverages. The CDMO Services Business Unit - comprising a Contract Development and Manufacturing Operation that offers pharmaceuticals, cosmeceuticals, nutraceuticals, and nutritions.
63GF Score
Get the complete analysis for BHST
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BHST has been successfully added to your 
